Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 Diabetes Mellitus
Contexto
Diabetes mellitus type 2
Questão
¿Should adults with type 2 diabetes mellitus be treated with dipeptidylpeptidase-4 inhibitors (such as sitagliptin), compared with other classes of oral hypoglycaemic medicines?